TRPM4 and cancer: Upregulation of miR-150 reduced TRPM4 expression in PC3 cells and resulted in inactivation of the β-catenin signaling pathway, leading to beneficial actions on cancer cells both in vitro (suppression of EMT, proliferation, migration, and invasion) and in vivo (restrained tumor growth and metastasis) [205].